Q: This one popped this am on the news that it's drug may actually work. Would you recommend buying it even after this am's pop? Thank you in advance for your comments.
Jason
Jason
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Would you update Knight;s share count following their buyback announced this summer? How many shares and floating shares are now outstanding?
Once they complete the purchase, do you think they will do a financing if they can get the share price back above ten dollars to finance possible future deals with their new company or possibly continue to pursue other deals.
Finally, how much cash will they be left with once they spend the $369M?
Thank you - very excited to see this deal!
Once they complete the purchase, do you think they will do a financing if they can get the share price back above ten dollars to finance possible future deals with their new company or possibly continue to pursue other deals.
Finally, how much cash will they be left with once they spend the $369M?
Thank you - very excited to see this deal!
Q: i had a small position in knight for years.
so the big deal finally happened.
my question is do you not think the stock should be a lot higher, who would sell on the news after waiting all this time. makes no sense and the deal looks great
so the big deal finally happened.
my question is do you not think the stock should be a lot higher, who would sell on the news after waiting all this time. makes no sense and the deal looks great
Q: I understand that Softbank's WeWork troubles might require it to unload some of its Guardant Health stake, but: shouldn't this be priced-in (to Guardant's share price) by now? Or are the details of Softbank's response to WeWork so all-over-the-place that nobody can guesstimate the collateral damage? Or has Guardant's decline put it in an end-of-year tax-loss vortext, such that it doesn't matter, now, what Softbank does?
Q: You must be glad Knight has finally done a big acquisition; please comment.
-
BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH)
-
iShares Global Healthcare Index ETF (CAD-Hedged) (XHC)
Q: Which stock or ETF would you recommend to buy in Health sector for TFSA? Need 11.4%. Used to own GUD but sold awhile ago with small loss. Don’t mind USA exposure but prefer to buy in CAN dollars.
Q: I have held BIIB since May and have gone nowhere, would it make sense to switch to MDT or do you have a better suggestion.
Q: I am looking at adding Akumin for some exposure to the health care field and like that they are Canadian but operate in the U.S. Could you please give me your thoughts on this company and its potential growth over the next 3-5 years.
Also, can you please tell me the difference between AKU;CA and AKU.U;CA, and which you would recommend buying.
thanks
Also, can you please tell me the difference between AKU;CA and AKU.U;CA, and which you would recommend buying.
thanks
Q: Sis has recovered nicely from its recent slide to $10.55,1 yr low,& up 3.39% today to close @ $12.81.Any reason(s)?Your opinion of the co now. Txs for u usual great services & views
Q: Wow,, what a jump in share value,, do I hold or sell my 7500 shares?
Q: What do you think of Citron's take on Bausch Health? The link is here: https://citronresearch.com/bausch-health-the-textbook-turnaround/
Q: This company looks interesting for the health care sector but the price has been dropping. Is there problems or opurtunity to buy.
Q: My only US “health care “ investment has gone south on me and I could really use your advice.....stick with it, bale out or change to a better performer. Can you help Me? Thanks guys and ladies.
Q: If the company becomes cash flow positive this quarter and they have a few wins outside of Texas, would you look at picking up coverage again? If not, under what conditions would you, if at all??
Q: Listed as AUPH on Nasdaq. On 9/13,it establishes At-the Market Facility to sell shares up to US$40m from time to time through Jefferies.Since then the price(US$6.59) had dropped sharply to US$3.88(close on Oct 14) Results of Phase 3 on its lead drug expected by year end.My Can $8.33 p/p had dropped 34.7% to a 1% position.Please comment on the company.Also should I buy,hold or sell?Txs for u usual great services & views
Q: Hi , what is your opinion of this company as a growth stock please? Thanks Rick
Q: Can I get your opinion on the latest news with Vitalhub entering into the Australia market? Thanks!
Q: Could you please comment on the new highs VMD and why PTQ has stop trading and are the two movements related. Does VMD own part of PTQ? Thank you for your assistance.
Q: I am curiuos about your take on Pharmagreen Biotech
Q: Good Morning.
Do you know why CYRX has been so volatile the last couple of days. There was an announcement about a new contract signing but the market should have digested it by now.
Thanks for your help.
Ian
Do you know why CYRX has been so volatile the last couple of days. There was an announcement about a new contract signing but the market should have digested it by now.
Thanks for your help.
Ian